Synthetic Human Growth Hormone Market

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Synthetic Human Growth Hormone Market contains market size and forecasts of Synthetic Human Growth Hormone in global, including the following market information:
Global Synthetic Human Growth Hormone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Synthetic Human Growth Hormone Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Synthetic Human Growth Hormone companies in 2021 (%)
The global Synthetic Human Growth Hormone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Synthetic Human Growth Hormone include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F.Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Synthetic Human Growth Hormone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Synthetic Human Growth Hormone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Synthetic Human Growth Hormone Market Segment Percentages, by Type, 2021 (%)
Powder
Solvent
Global Synthetic Human Growth Hormone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Synthetic Human Growth Hormone Market Segment Percentages, by Application, 2021 (%)
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Global Synthetic Human Growth Hormone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Synthetic Human Growth Hormone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Synthetic Human Growth Hormone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Synthetic Human Growth Hormone revenues share in global market, 2021 (%)
Key companies Synthetic Human Growth Hormone sales in global market, 2017-2022 (Estimated), (MT)
Key companies Synthetic Human Growth Hormone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F.Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
BioPartners